Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Canada Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20151
20161
20171
20181
20201
20217
20227
20238
202419
202528
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting91

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb10
AstraZeneca8
Merck Sharp & Dohme LLC8
University Health Network, Toronto5
Centre hospitalier de l'Université de Montréal (CHUM)4
Novartis Pharmaceuticals4
Pfizer4
AbbVie3
Hoffmann-La Roche3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung91
Lung Neoplasms27
Colorectal Neoplasms11
Neoplasms10
Carcinoma8
Breast Neoplasms6
Triple Negative Breast Neoplasms6
Melanoma5
Neoplasm Metastasis5
Pancreatic Neoplasms5

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.